Clinical Trial Update: Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adjuvant Xeloda (capecitabine) plus Eloxatin (oxaliplatin) with or without Avastin (bevacizumab) after radical resection of colorecta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Dutch Colorectal Cancer Group | Conditions: Colorectal Cancer, Liver Metastases | Phase 3 | Status: TERMINATED